Myeloablative and immunosuppressive properties of treosulfan in mice

This publication has 39 references indexed in Scilit:

• Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission
  British Journal of Haematology, 2002
• The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation
  British Journal of Haematology, 2000
• Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration
  Cancer Chemotherapy and Pharmacology, 1998
• Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation
  Cancer Chemotherapy and Pharmacology, 1995
• Pharmacokinetic and metabolic studies of high-dose busulphan in adults
  European Journal of Clinical Pharmacology, 1989
• Pneumopathies interstitielles au busulfan
  La Revue de Médecine Interne, 1988
• Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen
  Blood, 1987
• Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
  New England Journal of Medicine, 1983
• Busulphan and bone marrow depression.
  BMJ, 1969
• MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTION
  The Lancet, 1953